CONMED : Investor Presentation

Investor Presentation

Curt R. Hartman

Chair of the Board, President, and Chief Executive Officer

Todd W. Garner

Executive Vice President and Chief Financial Officer

November 15, 2022

Forward-Looking Information

This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks

and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's performance on a going-forward basis. The forward-looking statements in this presentation involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those

expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this presentation include, but are not limited to, the risks posed to the Company's business, financial condition, and results of operations by the COVID-19 global pandemic and the various government responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability; any assumptions underlying any of the foregoing, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2021 and other risks and uncertainties which may be detailed from time to time in reports filed by CONMED with the SEC, including the risks associated with the timing and costs related to the software implementation as further described in the risk factors listed in the Current Report filed on Form 8-K on November 15, 2022.

Management has disclosed adjusted financial measurements in this presentation that present financial information that is not in accordance with generally accepted accounting principles in the United States (GAAP). The Company analyzes net sales on a constant currency basis to better measure the comparability of results between periods. To measure earnings performance on a consistent and comparable basis, the Company excludes certain items that affect the comparability of operating results and the trend of earnings. These adjustments are irregular in timing, may not be indicative of past and future performance and are therefore excluded to allow investors to better understand underlying operating trends. These measurements are not a substitute for GAAP measurements. Investors should consider adjusted measures in addition to, and not as a substitute for, or superior to, financial performancemeasures prepared in accordance with GAAP.

2

CONMED Vision

Empower healthcare providers worldwide to deliver

exceptional outcomes for patients.

Focus behind the Vision

People, Products, Profitability

3

Objectives for Our Shareholders

▪ Aggregate growthand profitability over the long term to significantly

increase the valuation of the company

▪ Increase our market sharein large and attractive markets

▪ Deliver above-marketrevenueand profitability growthover the long term

4

Continuing to Shift the Mix of the Portfolio to Higher-Growth Products

	2015 *	YTD Sep 2019 *	YTD Sept 2022
Products Declining	79%	17%	16%
Products Growing Single Digits	21%	48%	42%
Products Growing Double Digits	0%	35%	42%

* Denotes latest disclosure of this metric at J.P. Morgan Conference, January 2020 (pre-pandemic)

5